Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Antitumor effect of a polypeptide fraction from Arca subcrenata in vitro and in vivo.

Hu X, Song L, Huang L, Zheng Q, Yu R.

Mar Drugs. 2012 Dec;10(12):2782-94.

2.

A new antiproliferative and antioxidant peptide isolated from Arca subcrenata.

Chen L, Song L, Li T, Zhu J, Xu J, Zheng Q, Yu R.

Mar Drugs. 2013 May 24;11(6):1800-14. doi: 10.3390/md11061800.

3.

Purification, characterization and in vitro anti-tumor activity of proteins from Arca subcrenata Lischke.

Song L, Ren S, Yu R, Yan C, Li T, Zhao Y.

Mar Drugs. 2008;6(3):418-30. doi: 10.3390/md20080020. Epub 2008 Jul 10.

4.

The inhibitory effect of a novel polypeptide fraction from Arca subcrenata on cancer-related inflammation in human cervical cancer HeLa cells.

Wu Y, Hu X, Song L, Zhu J, Yu R.

ScientificWorldJournal. 2014 Feb 9;2014:768938. doi: 10.1155/2014/768938. eCollection 2014.

5.

Polypeptide Fraction from Arca subcrenata Induces Apoptosis and G2/M Phase Arrest in HeLa Cells via ROS-Mediated MAPKs Pathways.

Hu X, Zhang Z, Liu T, Song L, Zhu J, Guo Z, Cai J, Yu R.

Evid Based Complement Alternat Med. 2015;2015:930249. doi: 10.1155/2015/930249. Epub 2015 May 21.

6.

In vitro and in vivo antineoplastic activity of a novel bromopyrrole and its potential mechanism of action.

Xiong S, Pang HD, Fan J, Ge F, Yang XX, Liu QY, Liao XJ, Xu SH.

Br J Pharmacol. 2010 Feb;159(4):909-18. doi: 10.1111/j.1476-5381.2009.00573.x. Epub 2010 Jan 8.

7.

Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers.

Li G, Yu K, Li F, Xu K, Li J, He S, Cao S, Tan G.

J Ethnopharmacol. 2014 Apr 28;153(2):521-30. doi: 10.1016/j.jep.2014.03.003. Epub 2014 Mar 12.

PMID:
24631140
8.

Fingerprint analysis of anti-tumor active polypeptides from Arca subcrenata by HPLC.

Ren SF, Song LY, Yan CY, Li TF, Zhao Y, Yu RM.

Zhong Yao Cai. 2008 Aug;31(8):1134-8.

PMID:
19112888
9.

Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.

Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.

Cancer Chemother Pharmacol. 2009 Jun;64(1):53-65. doi: 10.1007/s00280-008-0850-3. Epub 2008 Oct 19.

PMID:
18931998
10.

[In vitro anti-proliferation effect of peptides from cinobufacini injection].

Wu X, Gao B, Yang J, Bian BL, Wang HJ.

Yao Xue Xue Bao. 2012 Jun;47(6):822-6. Chinese.

PMID:
22919734
11.

Screening antitumor bioactive fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and sensitive cell lines with the serum pharmacology method and identification by UPLC-TOF-MS.

Gao SY, Gong YF, Sun QJ, Bai J, Wang L, Fan ZQ, Sun Y, Su YJ, Gang J, Ji YB.

Molecules. 2015 Mar 6;20(3):4290-306. doi: 10.3390/molecules20034290.

12.
13.

Mere15, a novel polypeptide from Meretrix meretrix, inhibits adhesion, migration and invasion of human lung cancer A549 cells via down-regulating MMPs.

Wang H, Wei J, Wu N, Liu M, Wang C, Zhang Y, Wang F, Liu H, Lin X.

Pharm Biol. 2013 Feb;51(2):145-51. doi: 10.3109/13880209.2012.715169. Epub 2012 Nov 8.

PMID:
23134156
14.

Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative.

Zhang Y, Zhang H, Chen J, Zhao H, Zeng X, Zhang H, Qing C.

Invest New Drugs. 2012 Feb;30(1):8-16. doi: 10.1007/s10637-010-9501-8. Epub 2010 Aug 14.

PMID:
20711631
15.

[Study on inhibitive effect of Limax extracts on Hela and study on the active component].

Chen L, Guo L, Wang Z.

Zhong Yao Cai. 2004 Feb;27(2):125-7. Chinese.

PMID:
22455003
16.

Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.

Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.

Chem Biol Interact. 2004 Jun 30;148(1-2):37-48.

PMID:
15223355
17.

HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: In vitro and in vivo anticancer effect.

Fang J, Greish K, Qin H, Liao L, Nakamura H, Takeya M, Maeda H.

Eur J Pharm Biopharm. 2012 Aug;81(3):540-7. doi: 10.1016/j.ejpb.2012.04.016. Epub 2012 Apr 30.

PMID:
22576132
18.

Species differences in troxacitabine pharmacokinetics and pharmacodynamics: implications for clinical development.

Gourdeau H, Leblond L, Hamelin B, Dong K, Ouellet F, Boudreau C, Custeau D, Richard A, Gilbert MJ, Jolivet J.

Clin Cancer Res. 2004 Nov 15;10(22):7692-702.

19.

Differential effects of anti-metastatic mechanism of Tian-Xian liquid (TXL) and its bioactive fractions on human colorectal cancer models.

Chu ES, Sze SC, Cheung HP, Wong KL, Liu Q, Ng TB, Tong Y.

J Ethnopharmacol. 2011 Sep 1;137(1):403-13. doi: 10.1016/j.jep.2011.05.035. Epub 2011 Jun 6.

PMID:
21669277
20.

7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.

Azéma J, Guidetti B, Dewelle J, Le Calve B, Mijatovic T, Korolyov A, Vaysse J, Malet-Martino M, Martino R, Kiss R.

Bioorg Med Chem. 2009 Aug 1;17(15):5396-407. doi: 10.1016/j.bmc.2009.06.053. Epub 2009 Jun 27.

PMID:
19595598

Supplemental Content

Support Center